PC
MNTA

Passport Capital’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Passport Capital’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-12,200
Closed -$142K – 265
2014
Q1 		$142K Buy
+12,200
New +$207K ﹤0.01% 179

Other funds holding MNTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Passport Capital's MNTA Position: Q2 2014 in Review

Passport Capital sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2014, closing a stake of 12,200 shares — an estimated $142K sold.

Passport Capital first reported a position in MNTA in Q1 2014 and held it in 1 quarter. The position peaked at $142K in Q1 2014. 148 funds tracked by Wall St. Rank hold MNTA as of Q2 2014.

  • Passport Capital reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2014 after selling out during the quarter.
  • Passport Capital sold 12,200 Momenta Pharmaceuticals, Inc. shares in Q2 2014, an estimated $142K.
  • Passport Capital first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and held it in 1 quarter.
  • Passport Capital's Momenta Pharmaceuticals, Inc. position peaked at $142K in Q1 2014.
  • 148 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2014.

Based on Passport Capital's 13F filing for Q2 2014, filed 14 Aug 2014.